Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ribapharm Inc. - RNA -- Ignore unavailable to you. Want to Upgrade?

To: REH who wrote (38)	5/14/2003 2:33:28 PM
From: Don Green	Read Replies (1) \| Respond to of 60

It isn't my problem, It is your obvious lack of ethics! Like this! using your own web site to imply additional interest! messages.yahoo.com I noticed you are also hot and heavy pumping on Yahoo BUYING by: cayflonor Long-Term Sentiment: Strong Buy 05/14/03 01:53 pm Msg: 1395 of 1395 Ribapharm Director Buys 10,000 Common Shares DOW JONES NEWSWIRES WASHINGTON -- Ribapharm Inc. (RNA ) director James Pieczynski bought 10,000 common shares, according to a filing Tuesday with the Securities and Exchange Commission. Pieczynski purchased the stock last Friday for $4.66 a share and held 10,000 shares after the transaction. Shares of pharmaceutical developer Ribapharm recently traded at $4.59, down 11 cents. -Robert L. Grant; Dow Jones Corporate Filings Alert; 202-393-7851 robert.grant@dowjones.com Updated May 13, 2003 3:49 p.m. BTW I thought I was on ignore? LOL!

To: REH who wrote (38)	5/14/2003 2:58:12 PM
From: Don Green	Read Replies (1) \| Respond to of 60

Drug Does Not Work Against SARS Matthew Herper, 04.11.03, 9:39 AM ET Scientists are increasingly certain they have identified the precise virus that causes severe acute respiratory syndrome. Unfortunately, one drug that has been widely tipped as a treatment for the disease does not kill the SARS virus in a petri dish, seriously denting any hope that the drug will be effective at treating SARS in people. "Ribavirin is not useful in killing this virus in cell culture," Stöhr said Thursday at the Biovision conference in Lyon, France. On the plus side, Stöhr said, the virus does not appear to be spread by cockroaches or mice. forbes.com